Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patients with the MELAS syndrome experience devastating mental impairment. This study will
evaluate the effectiveness of the drug dichloroacetate (DCA) to reduce the symptoms of MELAS.
Phase:
Phase 2
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)